Sonic Healthcare
Sonic Healthcare is a leading global provider of medical diagnostics services, specializing in laboratory medicine, radiology, and corporate medical services. With a strong presence in Australasia, Europe, and North America, Sonic Healthcare is renowned for its Medical Leadership culture, which prioritizes patient care and clinical excellence.
Short position
Sonic Healthcare (ASX:SHL) has 1.12% of its shares on issue reported as short positions as of 5 Oct 2026, or about 5,520,482 shares. Over the past 30 days that figure has risen 0.10 percentage points, and over 90 days it has fallen 5.35 percentage points. Its highest recorded short interest was 8.35% in August 2026. SHL is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Sonic Healthcare (SHL) financials
Results, ratios and statements
Latest result
Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency
- Revenue
- $10.87BM (source: ASX (Markit))vs $9.62B (FY25)
- ASX (Markit), as at 29 Sep 2026
- NPAT
- $608.3MM (source: ASX (Markit))vs $513.6M (FY25)
- ASX (Markit), as at 29 Sep 2026
- EPS (diluted)
- $1.23T (source: Derived: trailing 12 months at year end)vs $1.07 (FY25)
- Derived: trailing 12 months at year end, as at 29 Sep 2026
- Rev YoY
- +13.0%FY
- EPS YoY
- +15.3%TTM
- ASX (Markit)
- Derived: trailing 12 months at year end
Summary of Annual Report to shareholders, 24 Sep 2026
Sonic Healthcare delivered a strong FY2026 result with revenue up 13% to A$10.9 billion and underlying net profit up 17% to A$621 million. The Board declared a total dividend of A$1.08 per share, an increase on the prior year, and the company achieved its earnings guidance with strong organic growth of 5%.
Automated summary of the filing; the filing itself is the record.
Key ratios
Year to 30 Jun 2026 (FY); no balance sheet aligned with this period; prices to 9 Oct 2026
- Gross margin
- 83.5%
- Operating margin
- 9.2%
- Net margin
- 5.6%
- FCF margin
- 6.2%
- ROE
- n/a
- ROA
- n/a
- FCF conversion
- 1.10×
- Net debt (excl. leases)
- n/a
- Net debt / EBITDA
- n/a
- Current ratio
- n/a
- Interest cover
- 4.9×
- Cash dividends paid / net profit
- 90.6%
- Market cap
- n/a (no share count we can vouch for)
- P/E
- 15.2×
- P/B
- n/a (no share count we can vouch for)
Ratios use the reporting currency (AUD); market cap is in AUD. Sources: ASX (Markit) and Derived: trailing 12 months at year end, as at 29 Sep 2026.
Financial statements
Figures in AUD, the reporting currency; Yahoo Finance unless marked
| Line item | FY26 | FY25 | FY24 | FY23 |
|---|---|---|---|---|
| Revenue | $10.87BM (source: ASX (Markit)) | $9.62B | $8.93B | $8.14B |
| Gross profit | $9.08BT (source: Derived: trailing 12 months at year end) | $8.06B | $7.48B | $6.87B |
| Operating income | $1.00BT (source: Derived: trailing 12 months at year end) | $905.1M | $816.5M | $994.3M |
| EBITDA | $1.90BT (source: Derived: trailing 12 months at year end) | $1.68B | $1.66B | $1.72B |
| EBIT | $1.03BT (source: Derived: trailing 12 months at year end) | $869.4M | $882.0M | $1.02B |
| Interest expense | $203.3MT (source: Derived: trailing 12 months at year end) | $118.5M | $151.3M | $87.0M |
| Pretax income | $824.5MT (source: Derived: trailing 12 months at year end) | $750.9M | $730.7M | $931.2M |
| Tax | $188.2MT (source: Derived: trailing 12 months at year end) | $206.9M | $186.8M | $223.3M |
| NPAT | $608.3MM (source: ASX (Markit)) | $513.6M | $511.1M | $685.0M |
| Net interest income | −$203.3MT (source: Derived: trailing 12 months at year end) | −$158.8M | −$126.6M | −$73.4M |
| EPS basic | $1.23T (source: Derived: trailing 12 months at year end) | $1.07 | $1.07 | $1.46 |
| EPS diluted | $1.23T (source: Derived: trailing 12 months at year end) | $1.07 | $1.07 | $1.45 |
| Shares | n/a | 480.4M | 480.4M | 470.8M |
- ASX (Markit)
- Derived: trailing 12 months at year end
Financial reports
The company's own filings, newest first
- Annual Report to shareholdersAnnual Report24 Sep 2026via asx_announcements
- Preliminary Final Report FY2026Annual Results20 Aug 2026via asx_announcements
- Media Release - Full Year Results to 30 June 2026Full Year Results20 Aug 2026via asx_announcements
- CEO Presentation Half Year Results to 31 December 2025Half Year Results19 Feb 2026via asx_announcements
- Media Release Half Year Results to 31 December 2025Half Year Results19 Feb 2026via asx_announcements
- Half Yearly Report and AccountsHalf Year Results19 Feb 2026via asx_announcements
- Opens in new windowFinancial Report31 Dec 2025via crawler
- Financial ReportFinancial Report31 Dec 2025via crawler
- Annual Report to shareholdersAnnual Report24 Sep 2025via asx_announcements
- Media Release - Full Year Results to 30 June 2025Full Year Results21 Aug 2025via asx_announcements
Showing 10 of 30 reports